| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.082 | 0.2 |